Genomate is a fully integrated, automated high-throughput clinical tumor sequencing solution designed specifically to support in-hospital testing of our Core Product Genecast IVD Focus. This all-in-one system integrates the entire NGS workflow, including nucleic acid extraction, library preparation, real-time quality control, sequencing instrument automation, data analysis, and automatic report generation, allowing for true end-to-end testing. It enables seamless processing from FFPE tissue sample extraction to automated data analysis and report generation. The system is capable of delivering a ‘sample-in, report-out’ turnaround within 24 hours, with no manual intervention required at any stage of the process.

Genomate is designed to automate the entire process of clinical cancer sequencing, including nucleic acid extraction, library preparation, DNB generation, high-throughput sequencing, data analysis, and automated clinical report generation. The system is fully compatible with the Genecast IVD Focus kit, supporting dual DNA and RNA analysis of 41 cancer-relevant genes and MSI, with a low input requirement of 10 ng DNA and 50 ng RNA, and completing the sample-to-report cycle in just 24 hours.

Genomate is designed to offer scalable throughput (1-16 samples/run), making it suitable for both routine diagnostics and time-sensitive clinical decision-making. Real-time quality control across all steps, end-to-end sample traceability, and informatics-driven process monitoring ensure robustness, transparency, and regulatory compliance. Its compact design, equipped with a specialized airflow control system, minimizes contamination risk and supports deployment in space-constrained laboratories. Standardized, unattended workflows reduce human error, training time, and staffing burden, making the Genomate a future-ready, cost-effective solution for precision oncology diagnostics.